The device will be tested in high-risk percutaneous coronary intervention (PCI) patients.

Operators who performed at least 16 uLMS-PCIs per year were associated with improved survival.

The researchers explored data from orthotopic heart transplant patients who were hospitalized for COVID-19 at one of two facilities.

Fractional flow reserve guidance can help cardiologists make better decisions during percutaneous coronary intervention—can it lead to better outcomes for patients with stable angina pectoris?

When patients with coronary in-stent restenosis (ISR) require reintervention, should specialists turn to drug-coated balloon (DCB) angioplasty or a drug-eluting stent (DES)?

How should nonculprit lesions be evaluated? And when is the ideal time for complete revascularization?

Heart transplant (HT) recipients have an increased risk of experiencing severe complications if infected with COVID-19, according to new findings published in JAMA Cardiology.

What is the best way to determine—and improve—the quality of a PCI program?